HYDERABAD, Aug 14 (Reuters) - Indian pharmaceutical company Divi's Laboratories (DIVI.NS), opens new tab reported a 49.2% fall in quarterly profit, missing analysts' estimates, as the generic drug ...
At close, shares of Divi's Laboratories traded 1.65 per cent or Rs 59.65 higher, at Rs 3,681 apiece on the BSE. The market ...
Aug 6 (Reuters) - India's Divi's Laboratories (DIVI.NS), opens new tab reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic drugs continued to be negatively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results